Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder.

Hart AB, Gamazon ER, Engelhardt BE, Sklar P, Kähler AK, Hultman CM, Sullivan PF, Neale BM, Faraone SV, Psychiatric Genomics Consortium: ADHD Subgroup, de Wit H, Cox NJ, Palmer AA
Proc Natl Acad Sci U S A. 2014 111 (16): 5968-73

PMID: 24711425 · PMCID: PMC4000861 · DOI:10.1073/pnas.1318810111

MeSH Terms (13)

Attention Deficit Disorder with Hyperactivity Bipolar Disorder Dextroamphetamine Euphoria Genetic Predisposition to Disease Genetic Variation Humans Phenotype Polymorphism, Single Nucleotide Protective Agents Reproducibility of Results Risk Factors Schizophrenia

Connections (2)

This publication is referenced by other Labnodes entities: